Australia markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
166.42+2.07 (+1.26%)
At close: 04:00PM EDT
166.38 -0.04 (-0.02%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close164.35
Bid165.85 x 800
Ask167.00 x 1200
Day's range164.49 - 166.49
52-week range130.96 - 182.89
Avg. volume5,612,977
Market cap293.876B
Beta (5Y monthly)0.59
PE ratio (TTM)49.53
EPS (TTM)3.36
Earnings date25 July 2024 - 29 July 2024
Forward dividend & yield6.20 (3.73%)
Ex-dividend date12 Apr 2024
1y target est182.41
  • PR Newswire

    AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®

    AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.

  • The Real Deal

    AbbVie CEO latest heavy hitter to buy in Boca Raton

    AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city. Records show Gonzalez bought the house at 650 Tern Point Circle in Boca Raton’s […]The post AbbVie CEO latest heavy hitter to buy in Boca Raton appeared first on The Real Deal.

  • Zacks

    Are You Looking for a High-Growth Dividend Stock?

    Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.